Brief: Diasorin Gets Clearance From Fda For Second Blood Infection Panel On Liaison Plex

Diasorin

22/04/2025 10:02

April 22 (Reuters) - DiaSorin SpA DIAS.MI:

RECEIVED CLEARANCE FROM U.S. FDA FOR SECOND BLOOD INFECTION PANEL ON LIAISON PLEX

LIAISON PLEX PART OF THREE PANELS OF MULTIPLEX MOLECULAR TESTS FOR IDENTIFYING BLOODSTREAM INFECTIONS

DETECTS 27 TARGETS, INCLUDING 19 GRAM-NEGATIVE PATHOGENIC BACTERIA, RESISTANCE GENES, COMPLETES CURRENT DIAGNOSTIC WORK-UP, REDUCES OPERATIONAL COSTS

 Further company coverage: DIAS.MI

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))